Valneva raises €88 million
Valneva, a specialty vaccine company, announced today that the underwriters of its global offering of an aggregate of 4,500,000 new... View Article
Innovative medical device same™ by i-SEP : promising clinical results
MedTech – Autotransfusion or IntraOperative Cell Recovery Recovery of platelets in addition to red blood cells, a world premiere Following... View Article
KetoM+ is launching Cétoprane, a ketogenic medical food (DADFMS)
KetoM+, member of our network based in Le Mans, is launching Cétoprane, a ketogenic medical food (DADFMS) nutritionally adapted for... View Article
New member | Elisabeth Richard Business Development Consulting
Elisabeth Richard BD Consulting offers a business development (France and International) expertise in the fields of health and innovation having... View Article
Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
VLA2001 successfully met both co-primary endpoints Superior neutralizing antibody titer levels compared to active comparator vaccine, AstraZeneca’s AZD1222 (ChAdOx1-S) Neutralizing... View Article
Owkin joins OPTIMA: new research project to improve the treatment of prostate, breast and lung cancer patients using AI
Owkin is delighted to be part of OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence),... View Article
Hawkcell & Cynbiose team up in a strategic partnership
Cynbiose SAS, a preclinical CRO, and HawkCell, a young innovative company specialized in MRI (Magnetic Resonance Imaging) for small and... View Article
OSE Immunotherapeutics Receives New European Patent Notice of Allowance for Tedopi®
Further Strengthens Global Intellectual Property Portfolio for Tedopi® until 2038 OSE Immunotherapeutics announced today that it has received notice of... View Article
Atlanpole Biotherapies – spearheading the development of tomorrow’s healthcare industry
2020/2021: THE CLUSTER IS COMMITTED TO SUPPORTING ITS MEMBERS Faced with the current health crisis, cluster members rallied strongly and... View Article
Focus on the Atlanpole Biotherapies 2021 General Assembly
The 2021 General Assembly was attended by close to 150 people, providing an opportunity to review and assess the cluster’s... View Article